0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Taxol"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Ovarian Cancer Drugs Market Report 2025 - Product Thumbnail Image

Ovarian Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,600USDGBP
  • 4 Results (Page 1 of 1)
Loading Indicator

Taxol is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It is a semi-synthetic derivative of the Pacific yew tree and is administered intravenously. Taxol works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is often used in combination with other drugs to increase its effectiveness. Taxol is one of the most widely used drugs for the treatment of lung cancer. It is often used in combination with other drugs, such as cisplatin, to increase its effectiveness. It is also used in combination with radiation therapy to reduce the risk of recurrence. Taxol is generally well tolerated, but can cause side effects such as nausea, vomiting, and hair loss. The Taxol market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more